BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » AASCP is Proud to Add Dr. Scheffer Tseng, Accalimed Opthamologist and Founder of Bio-Tissue Products, to Its Speaker Roster
AASCP Dr Scheffer Tseng Bio-Tissue

AASCP is Proud to Add Dr. Scheffer Tseng, Accalimed Opthamologist and Founder of Bio-Tissue Products, to Its Speaker Roster

April 25, 2022 By Cade Hildreth (CEO) Leave a Comment

The American Academy of Stem Cell Physicians (AASCP) will meet on June 17-19, 2022, and be offering hands on workshops.

MIAMI, April 27, 2022 – The American Academy of Stem Cell Physicians (AASCP) is proud to welcome the acclaimed Ophthalmologist Dr. Scheffer Tseng as a Guest Speaker for its upcoming conference on June 17-19, 2022 in Miami, Florida. At this event, the AASCP will host expert speakers from across the country lecturing on the innovations in stem cell research and how they can be safely and effectively applied to patient populations in accordance with current regulations. Hands on workshops will also be offered.

“The Academy is proud to offer state-of-the-art Regenerative Workshops this June at its annual event. These workshops will be lead by experts with over 100 years of combined experience,” said Dr. Sunny Kim, President of the AASCP.

Dr. Scheffer Tseng is a highly regarded pioneer and practicing ophthalmologist located in Miami Florida. He will be presenting on June 18th, the second day of the AASCP’s annual conference. Dr. Scheffer Tseng co-founded the companies TissueTech and Bio-Tissue and is currently Chief Technology Officer (CTO) for TissueTech. Additionally, Dr. Tseng is a world-class surgeon specializing in ocular surface reconstruction and is a widely published physician scientist with more than 380 peer-reviewed clinical and scientific papers.

For the past 35 years, Dr. Tseng has specialized in identifying the active biological components contained within human placental tissues in order to develop therapeutic products and to expand the clinical applications of these important perinatal tissues.

Dr. Tseng shares, “I know how important it is to maintain the highest standards in clinical care for both my practice and my patients. As a research scientist, I know how critical quality data is to the development of strategies and therapies that can truly impact patient care and improve clinical outcomes. For more than 30 years, I have been dedicated to making a positive difference in the lives of my patients.”

The American Academy of Stem Cell Physicians invites you to learn more about how Bio-Tissue can help assist patients with a number of ocular surface and lid margin diseases. Dr. Tseng went on to add, said, “I am looking forward to discussing all of the new advancements within the Regenerative Field in 2022.”

The spokesman for the AASCP, Dr. AJ Farshchian, said earlier: “The American Academy of Stem Cell Physicians is a group of physicians, scientists, and researchers who collectively represent the most authoritative non-federal group advocating for guidelines and education on stem cell therapy and regenerative medicine. The AASCP is involved directly with other authorities within the field and seeks only to bring knowledge and awareness for the ever-growing regenerative medicine industry.”

AASCP is hosting its medical conference in Miami on June 17-19, 2022. The conference is taking place at the downtown Miami Hyatt Regency, located at 400 SE 2nd Ave., Miami, FL 33131. Because of limited seating, attendees are encouraged to RSVP at AASCP.net and to register. Registration prices for the early bird ticket special are currently $1,500.00, but the price will rise to $2,500.00 in one week on May 1, 2022.

Register today to benefit from early bird pricing.

About the AASCP

The American Academy of Stem Cell Physicians (AASCP) is an organization created to advance research and the development of therapeutics in regenerative medicine, including diagnosis, treatment and prevention of disease related to or occurring within the human body. Secondarily, the AASCP aims to serve as an educational resource for physicians, scientists and the public in diseases that can be caused by physiological dysfunction that are ameliorable to medical treatment.

For further information, please contact Wilson Demenessez or Lana Ingrid of the AASCP at phone number 305-891-4686 or visit the AASCP online at www.aascp.net.

Source: AASCP

5/5 - (1 vote)

Filed Under: Press Releases, Stem Cell News

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.